Cessatech A/S

Biotechnology·CESSA · Nasdaq Copenhagen

Development of medicines for children. Listed on Spotlight Stock Market.

Financial figures

Revenue latest fiscal year	N/A
Revenue growth vs. the year before, same method	N/A
EBITDA reported by the company	N/A
Net debt debt incl. leasing minus cash	N/A
Diluted EPS per share	N/A

Source: annual report (ESEF) A.

Criteria

Profit	N/A
Growing	N/A
Healthy balance sheet	N/A

Only the criteria that can be computed from financial statements on this page. The remaining criteria (such as price and dividend) need a share price and are in the analysis.

This page doesn't have a profile from the annual report yet. It's coming with the next reporting round. Run an analysis to investigate Cessatech A/S against your own view.